Summary: Cagrilintide and retatrutide are investigational injectable medicines being studied for obesity and type 2 diabetes in men, targeting multiple hormonal pathways to reduce appetite, improve blood glucose control, and increase energy expenditure, but neither is currently licensed in the UK
The results showed a significant negative relationship between UA levels and the progression rate of ALS [130]
Incorporating drugs with different mechanisms and personalized medicine may improve the efficacy to better benefit patients with NAFL/NASH
Of all the genetic variations identified to date, MS stands alone as a degenerative CNS disorder with no mutation that causes MS
Yang K, Han L, Wu S, Qu X, Li Q, Zhao C, et al
I knew that if I could remain consistent and do my best, I could expect changes